🗞️ Good News: You will now receive the Goodnewsletter every day!

Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday.  ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

​ ​ ​ Success! You will now receive good news every day! Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday. Didn’t mean to click the ‘switch to daily’ link? No sweat! ​Click here to switch back to weekly good news emails.​ Don’t want to wait for good news? Start now: → Read new good news → Get a good news newspaper ​ Good Good Good shares stories and tools designed to leave you feeling less overwhelmed, more hopeful, and ready to make a difference. We also create a monthly print newspaper called the Goodnewspaper. You should try it! You received this email because you switched your Goodnewsletter subscription settings. ​Contact us​ ​Unsubscribe​ ​

🗞️ Good News: You will now receive the Goodnewsletter every day!

Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday.  ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

​ ​ ​ Success! You will now receive good news every day! Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday. Didn’t mean to click the ‘switch to daily’ link? No sweat! ​Click here to switch back to weekly good news emails.​ Don’t want to wait for good news? Start now: → Read new good news → Get a good news newspaper ​ Good Good Good shares stories and tools designed to leave you feeling less overwhelmed, more hopeful, and ready to make a difference. We also create a monthly print newspaper called the Goodnewspaper. You should try it! You received this email because you switched your Goodnewsletter subscription settings. ​Contact us​ ​Unsubscribe​ ​

🗞️ Good News: You will now receive the Goodnewsletter every day!

Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday.  ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

​ ​ ​ Success! You will now receive good news every day! Thanks for switching to daily good news! You can expect the Goodnewsletter to arrive in your inbox every day, Monday through Friday. Didn’t mean to click the ‘switch to daily’ link? No sweat! ​Click here to switch back to weekly good news emails.​ Don’t want to wait for good news? Start now: → Read new good news → Get a good news newspaper ​ Good Good Good shares stories and tools designed to leave you feeling less overwhelmed, more hopeful, and ready to make a difference. We also create a monthly print newspaper called the Goodnewspaper. You should try it! You received this email because you switched your Goodnewsletter subscription settings. ​Contact us​ ​Unsubscribe​ ​

Free, Live ADAA Webinar on Sept 17 | Ketamine, Esketamine, and Emerging Psychedelics in the Future of Mental Health

Free Live Webinar - Register Today!

PERSONAL STORIES WEBINARS FIND HELP

Free Live Webinar | Thursday, September 17 | 1 PM ET Join us on Thursday, September 17, for a free, live presentation by Robert Meisner, MD, to explore what is currently known about ketamine and esketamine, including how these treatments work, who may benefit from them, potential risks, and what treatment can look like in practice. Discussion will include ketamine-assisted psychotherapy, including how psychotherapy may complement medication treatment and what researchers do, and do not, know about the potential benefits of combining the two.   Looking beyond ketamine, we’ll discuss emerging psychedelic-based treatments and new therapies currently being studied for depression, anxiety, and other mental health conditions. Throughout the presentation, we’ll distinguish established scientific evidence from promising but unproven theories. Our goal is to separate hope from hype and provide a clear, evidence-informed look at where mental health treatment may be headed.   By the end of this webinar, participants will be able to: Explain the differences between ketamine and esketamine, including how they work, potential benefits and risks, and what treatment may involve. Describe current approaches to ketamine-assisted psychotherapy and distinguish established evidence from theories and practices that have not yet been adequately studied. Discuss emerging psychedelic-based treatments and other novel therapies being studied for depression, anxiety, and related mental health conditions, including what is known about their potential benefits and limitations. Register Now   Translating ADAA Live Webinars

Meet the Presenter Robert C. Meisner, MD, is the founding Medical Director of The McLean Ketamine Service (McLean Hospital) and a Child and Adult attending psychiatrist in the Emergency Department (Acute Psychiatric Service) at the Massachusetts General Hospital. He serves on the MassGenBrigham Psychedelic Center Working Group and as Co-Chair of the National Network of Depression Center’s (NNDC) Ketamine Task Group. A co-recipient of its Momentum Grant, he serves on the Steering Committee for the Standards and Best Practices Catalyst Committee Conference, tasked with launching a year-long effort to establish granular, evidence-based, national consensus guidelines. Learn more about Robert Meisner Please note: this public webinar is not eligible for continuing education credits. View all ADAA Webinars Visit the ADAA Bookstore Watch "Who is ADAA?

Contribute to ADAA Anxiety and Depression Association of America 8701 Georgia Avenue, Suite 412 Silver Spring, MD 20910 240-485-1001 www.adaa.org   If you no longer wish to receive these emails Unsubscribe